Name: SYKES & RAY EQUITIES (I) LTD.
Address: 3rd Floor, Cama Building, Dalal St, Kala Ghoda, Fort, Mumbai, 400001, IN
Telephone: 022 6193 7300

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Vaishali Pharma Ltd.

Jul 04 NSE 11.43( -0.02 -0.17%)

Volume689055

Prev. Close
11.45

Open Price
11.49

Today's Low / High

11.34 11.54

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

10.30 24.91

Standalone

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	97.88	81.76	63.82	75.82	52.31
Other Operating Revenues	1.14	4.52	5.84	0.00	1.47
Total Operating Revenues	99.03	86.28	69.66	75.82	53.77

Other Income	3.21	2.03	2.23	1.79	1.81
Total Revenue	102.23	88.31	71.89	77.61	55.58

EXPENSES
Purchase Of Stock-In Trade	90.10	71.75	57.10	63.54	45.86
Changes In Inventories Of FG,WIP And Stock-In Trade	-4.43	2.67	-2.42	-0.04	0.29
Employee Benefit Expenses	2.58	2.32	2.08	2.10	1.85
Finance Costs	1.58	1.74	2.01	2.46	2.61
Depreciation And Amortisation Expenses	0.49	0.51	0.50	0.46	0.43
Other Expenses	10.68	8.40	3.77	3.37	3.14
Total Expenses	101.01	87.39	63.05	71.88	54.18

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1.23	0.93	8.85	5.73	1.40

Profit/Loss Before Tax	1.23	0.93	8.85	5.73	1.40

Tax Expenses-Continued Operations
Current Tax	0.41	0.25	2.16	1.45	0.38
Deferred Tax	0.00	-0.04	0.00	-0.02	-0.02
Tax For Earlier Years	0.00	0.00	0.08	0.27	0.00
Total Tax Expenses	0.41	0.21	2.24	1.70	0.36
Profit/Loss After Tax And Before ExtraOrdinary Items	0.82	0.72	6.60	4.02	1.05

Profit/Loss From Continuing Operations	0.82	0.72	6.60	4.02	1.05

Profit/Loss For The Period	0.82	0.72	6.60	4.02	1.05

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	0.31	0.68	6.26	3.82	0.99
Diluted EPS (Rs.)	0.31	0.64	5.91	3.82	0.99

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	2.00

INCOME
Revenue From Operations [Net]	97.88
Other Operating Revenues	1.14
Total Operating Revenues	99.03
Other Income	3.21
Total Revenue	102.23
EXPENSES
Purchase Of Stock-In Trade	90.10
Changes In Inventories Of FG,WIP And Stock-In Trade	-4.43
Employee Benefit Expenses	2.58
Finance Costs	1.58
Depreciation And Amortisation Expenses	0.49
Other Expenses	10.68
Total Expenses	101.01
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1.23
Profit/Loss Before Tax	1.23
Tax Expenses-Continued Operations
Current Tax	0.41
Deferred Tax	0.00
Tax For Earlier Years	0.00
Total Tax Expenses	0.41
Profit/Loss After Tax And Before ExtraOrdinary Items	0.82
Profit/Loss From Continuing Operations	0.82
Profit/Loss For The Period	0.82
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	0.31
Diluted EPS (Rs.)	0.31